Quail, D. F. &
Joyce, J. A.
Microenvironmental regulation of tumor progression and metastasis.
19, 1423–1437 (2013)
et al. Ultraviolet-radiation-induced inflammation promotes
angiotropism and metastasis in melanoma. Nature
507, 109–113 (2014)
Galdiero, M. R.
et al. Tumor associated macrophages and neutrophils in cancer.
218, 1402–1410 (2013)
et al. MET is required for the recruitment of anti-tumoural
522, 349–353 (2015)
Aburatani, H. &
Tumour-mediated upregulation of chemoattractants and recruitment of myeloid
cells predetermines lung metastasis. Nature Cell Biol.
8, 1369–1375 (2006)
Erler, J. T.
et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone
marrow cell recruitment to form the premetastatic niche. Cancer
15, 35–44 (2009)
Kaplan, R. N.
et al. VEGFR1-positive haematopoietic bone marrow progenitors
initiate the pre-metastatic niche. Nature
438, 820–827 (2005)
et al. Interactions between cancer stem cells and their niche govern
metastatic colonization. Nature
481, 85–89 (2012)
et al. Dependency of colorectal cancer on a TGF-β-driven
program in stromal cells for metastasis initiation. Cancer
22, 571–584 (2012)
Batlle, E. &
Metastatic stem cells: sources, niches, and vital pathways. Cell
14, 306–321 (2014)
Coffelt, S. B.
et al. IL-17-producing γδ T cells and
neutrophils conspire to promote breast cancer metastasis.
522, 345–348 (2015)
Luu, N. T., Rainger, G. E., Buckley, C. D. & Nash, G. B.
CD31 regulates direction and rate of neutrophil migration over and under
endothelial cells. J. Vasc. Res.
40, 467–479 (2003)
Youn, J. I. &
Gabrilovich, D. I.
Regulation of tumor metastasis by myeloid-derived suppressor cells.
Annu. Rev. Med.
66, 97–110 (2015)
Qian, B. Z.
et al. CCL2 recruits inflammatory monocytes to facilitate
breast-tumour metastasis. Nature
475, 222–225 (2011)
et al. Circulating breast tumor cells exhibit dynamic changes in
epithelial and mesenchymal composition. Science
339, 580–584 (2013)
Korkaya, H., Liu, S. & Wicha, M. S.
Breast cancer stem cells, cytokine networks, and the tumor
microenvironment. J. Clin. Invest.
121, 3804–3809 (2011)
et al. CCL2 mediates cross-talk between cancer cells and stromal
fibroblasts that regulates breast cancer stem cells. Cancer
72, 2768–2779 (2012)
Yan, H. H.
et al. Gr-1+CD11b+ myeloid cells tip
the balance of immune protection to tumor promotion in the premetastatic
lung. Cancer Res.
70, 6139–6149 (2010)
Strosberg, A. D.,
Bouaouina, N., Ben Ahmed, S. &
Genetic variation in pro-inflammatory cytokines
(interleukin-1β, interleukin-1α and interleukin-6)
associated with the aggressive forms, survival, and relapse prediction of
breast carcinoma. Eur. Cytokine Netw.
16, 253–260 (2005)
Wang, D. &
Dubois, R. N.
Eicosanoids and cancer. Nature Rev. Cancer
10, 181–193 (2010)
Cho, N. K., Joo, Y. C., Wei, J. D., Park, J. I. &
Kim, J. H.
BLT2 is a pro-tumorigenic mediator during cancer progression and a
therapeutic target for anti-cancer drug development. Am. J.
3, 347–355 (2013)
Kanaoka, Y. &
Boyce, J. A.
Cysteinyl leukotrienes and their receptors: cellular distribution and
function in immune and inflammatory responses. J. Immunol.
173, 1503–1510 (2004)
Hiraga, T., Ito, S. & Nakamura, H.
Side population in MDA-MB-231 human breast cancer cells exhibits cancer
stem cell-like properties without higher bone-metastatic potential.
et al. CD44+/CD24− breast
cancer cells exhibit enhanced invasive properties: an early step necessary
for metastasis. Breast Cancer Res.
8, R59 (2006)
Lo, P. K.
et al. CD49f and CD61 identify Her2/neu-induced mammary
tumor-initiating cells that are potentially derived from luminal progenitors
and maintained by the integrin-TGFβ signaling.
31, 2614–2626 (2012)
Park, M. K.
et al. Novel involvement of leukotriene B4 receptor 2
through ERK activation by PP2A down-regulation in leukotriene
B4-induced keratin phosphorylation and reorganization of
pancreatic cancer cells. Biochim. Biophys. Acta
1823, 2120–2129 (2012)
Wenzel, S. E. &
Kamada, A. K.
Zileuton: the first 5-lipoxygenase inhibitor for the treatment of
asthma. Ann. Pharmacother.
30, 858–864 (1996)
Immunomonitoring and prognostic relevance of neutrophils in clinical
trials. Semin. Cancer Biol.
23, 200–207 (2013)
et al. Prognostic value of chemotherapy-induced neutropenia in
early-stage breast cancer. Breast Cancer Res. Treat.
131, 483–490 (2012)
Guy, C. T.,
Cardiff, R. D.&
Muller, W. J.
Induction of mammary tumors by expression of polyomavirus middle T
oncogene: a transgenic mouse model for metastatic disease. Mol.
12, 954–961 (1992)
Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T.
& Nishimune, Y.
‘Green mice’ as a source of ubiquitous green
cells. FEBS Lett.
407, 313–319 (1997)
Lieschke, G. J.
et al. Mice lacking granulocyte colony-stimulating factor have
chronic neutropenia, granulocyte and macrophage progenitor cell deficiency,
and impaired neutrophil mobilization. Blood
84, 1737–1746 (1994)
et al. RAG-1-deficient mice have no mature B and T
68, 869–877 (1992)
Cao, Y. A.
et al. Shifting foci of hematopoiesis during reconstitution from
single stem cells. Proc. Natl Acad. Sci. USA
101, 221–226 (2004)
et al. In vivo genetic ablation by Cre-mediated expression of
diphtheria toxin fragment A. Genesis
43, 129–135 (2005)
et al. Impaired immunity and enhanced resistance to endotoxin in the
absence of neutrophil elastase and cathepsin G. Immunity
12, 201–210 (2000)
Chen, X. S., Sheller, J. R., Johnson, E. N. & Funk, C. D.
Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase
372, 179–182 (1994)
Daley, J. M., Thomay, A. A., Connolly, M. D., Reichner, J. S.
& Albina, J. E.
Use of Ly6G-specific monoclonal antibody to deplete neutrophils in
mice. J. Leukoc. Biol.
83, 64–70 (2008)
Bao, Y. &
Revisiting the protective and pathogenic roles of neutrophils: Ly-6G is
Eur. J. Immunol.
41, 2535–2538 (2011)